According to these studies, the oncogenic and tumor suppressive roles of EZH2 in cancer progression depend on its associated targets, post-translational modifications such as phosphorylation and methylation, and the cancer microenvironment such as hypoxia status. Here, EZH2 is linked to neoplasm.